SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-034882
Filing Date
2021-06-29
Accepted
2021-06-29 07:05:20
Documents
14
Period of Report
2021-06-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ortx-8k_20210629.htm   iXBRL 8-K 42352
2 EX-99.1 ortx-ex991_8.htm EX-99.1 36685
3 GRAPHIC gxd0eitfiawb000001.jpg GRAPHIC 8463
  Complete submission text file 0001564590-21-034882.txt   226373

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ortx-20210629.xsd EX-101.SCH 5784
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20210629_lab.xml EX-101.LAB 18640
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20210629_pre.xml EX-101.PRE 11155
7 EXTRACTED XBRL INSTANCE DOCUMENT ortx-8k_20210629_htm.xml XML 3473
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 211055565
SIC: 2836 Biological Products, (No Diagnostic Substances)